Brand name
Vivelle-Dot, the original
We didn’t find a savings card or cash price from Vivelle-Dot’s maker. Ask the pharmacy for Vivelle-Dot’s cash price. With insurance, ask what your plan charges.
Generic name: estradiol
Used for: Hot flashes from menopause · Vaginal dryness from menopause (vaginal atrophy) · Preventing osteoporosis after menopause · Low estrogen (hypoestrogenism) · 3 more
Ask for the cash price
Generic estradiol
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as Vivelle-Dot, and the FDA requires it to work the same way.
Vivelle-Dot, the original
We didn’t find a savings card or cash price from Vivelle-Dot’s maker. Ask the pharmacy for Vivelle-Dot’s cash price. With insurance, ask what your plan charges.
The same medicine as Vivelle-Dot, without the brand name
The same medicine as Vivelle-Dot, without the brand name. Its NDC is the number that names the exact product: give it to the pharmacy and they can look it up or order it.
estradiol
Pick your strength
Give the pharmacy this NDC
What to say at the pharmacy
“Before you fill my Vivelle-Dot, can you tell me what I’d pay for the brand, for the authorized generic from Sandoz (NDC ), and for a regular generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Source: FDA, updated November 16, 2026
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
0.025 mg/day patch
Same active and inactive ingredients as Vivelle-Dot.
Active: estradiol 0.025 mg/day
Inactive, on both labels:
0.0375 mg/day patch
Same active and inactive ingredients as Vivelle-Dot.
Active: estradiol 0.0375 mg/day
Inactive, on both labels:
0.05 mg/day patch
Same active and inactive ingredients as Vivelle-Dot.
Active: estradiol 0.05 mg/day
Inactive, on both labels:
0.075 mg/day patch
Same active and inactive ingredients as Vivelle-Dot.
Active: estradiol 0.075 mg/day
Inactive, on both labels:
0.1 mg/day patch
Same active and inactive ingredients as Vivelle-Dot.
Active: estradiol 0.1 mg/day
Inactive, on both labels:
Same active ingredient as Vivelle-Dot. Fillers and dyes can differ.
3 companies sell a generic of Vivelle-Dot that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Sold as Dotti
0.025 mg/day Round
| Package | NDC |
|---|---|
| Carton of 8 | 65162-989-08 |
0.0375 mg/day Round
| Package | NDC |
|---|---|
| Carton of 8 | 65162-992-08 |
0.05 mg/day Round
| Package | NDC |
|---|---|
| Carton of 8 | 65162-993-08 |
0.075 mg/day Round
| Package | NDC |
|---|---|
| Carton of 8 | 65162-995-08 |
0.1 mg/day Round
| Package | NDC |
|---|---|
| Carton of 8 | 65162-997-08 |
Inactive ingredients: dimethiconol/trimethylsiloxysilicate crosspolymer (40/60 w/w; 1000000 pa.s), oleyl alcohol, povidone, dipropylene glycol
0.025 mg/day
| Package | NDC |
|---|---|
| Carton of 28 | 0378-4644-26 |
0.0375 mg/day
| Package | NDC |
|---|---|
| Carton of 28 | 0378-4643-26 |
0.05 mg/day
| Package | NDC |
|---|---|
| Carton of 28 | 0378-4642-26 |
0.075 mg/day
| Package | NDC |
|---|---|
| Carton of 28 | 0378-4641-26 |
0.1 mg/day
| Package | NDC |
|---|---|
| Carton of 28 | 0378-4640-26 |
Inactive ingredients: dipropylene glycol, povidone, oleyl alcohol
0.025 mg/day
| Package | NDC |
|---|---|
| Box of 28 | 70710-1191-8 |
0.0375 mg/day
| Package | NDC |
|---|---|
| Box of 28 | 70710-1192-8 |
0.05 mg/day
| Package | NDC |
|---|---|
| Box of 28 | 70710-1193-8 |
0.075 mg/day
| Package | NDC |
|---|---|
| Box of 28 | 70710-1194-8 |
0.1 mg/day
| Package | NDC |
|---|---|
| Box of 28 | 70710-1195-8 |
Inactive ingredients: oleic acid, povidone, propylene glycol, silicon dioxide
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
VIVELLE-DOT is an estrogen indicated for:
Limitations of Use When prescribing solely for the treatment of moderate to severe vaginal atrophy, first consider the use of topical vaginal products.
Limitations of Use When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
Source: the FDA label for Vivelle-Dot (Sandoz Inc), October 30, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/vivelle-dot/